跳至主要内容
临床试验/NCT00612950
NCT00612950已完成不适用

Four Weeks of Near Normalisation of Blood Glucose Improves the Insulin Response to GLP-1 and GIP in Patients With Type 2 Diabetes

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2006年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
2.phase insulin response measured as incremental area under the curve from 10-120 minutes

研究概览

简要总结

The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 respectively. The aim of the present study was to investigate whether 4 weeks of near-normalization of blood glucose could improve the insulin responses to GIP and GLP-1 in patients with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70 years
  • Type 2 diabetes diagnosed after 30 years of age
  • BMI > 25

排除标准

  • Severe complications to diabetes
  • Abnormal liver and kidney function
  • Haemoglobin below the lower limit
  • Macroalbuminuria
  • Systemic disease
  • Pregnancy

研究组 & 干预措施

GLP-1

Experimental

干预措施: glucagon-like peptide-1, (Drug)

GIP

Experimental

干预措施: glucose dependent insulinotropic polypeptide (Drug)

saline

Placebo Comparator

干预措施: Saline (Drug)

结局指标

主要结局

2.phase insulin response measured as incremental area under the curve from 10-120 minutes

时间窗: 2 hours

次要结局

  • 2.phase insulin response measured as incremental area under the curve from 10-120 minutes, after 4 weeks of insulin treatment(2 hours)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验